Neuroendocrine aspects of hypercortisolism in major depression.
Researchers observed that major depression is associated with altered HPA axis physiology, including hypersecretion of ACTH and cortisol during acute episodes.
Adrenocorticotropic Hormone · Corticotropin · Acthar
Adrenocorticotropic hormone (ACTH), a peptide hormone produced by the anterior pituitary gland, plays a crucial role in stimulating cortisol secretion from the adrenal glands. Researchers primarily study ACTH to understand its involvement in various endocrine disorders, particularly Cushing's disease, which is characterized by excessive ACTH production due to pituitary adenomas. Key findings indicate that elevated ACTH levels lead to increased cortisol, resulting in significant health issues such as hypertension, obesity, and metabolic syndrome. Furthermore, studies suggest that effective management of conditions related to ACTH dysregulation, including surgical resection of adenomas, can lead to biochemical remission and improved patient outcomes. Current research continues to explore the complexities of ACTH regulation and its implications for treatment strategies in related disorders.
Adrenocorticotropic hormone (ACTH), also known as corticotropin or Acthar, is an endogenous peptide hormone produced by the anterior pituitary gland. It belongs to the class of pituitary and trophic hormones. ACTH is synthesized as part of a larger precursor molecule, proopiomelanocortin (POMC), and is cleaved to produce the active hormone. It plays a crucial role in the endocrine system by regulating the secretion of glucocorticoids from the adrenal cortex. Researchers have observed that ACTH is primarily involved in the stress response, influencing the production of cortisol, a key stress hormone. It is also implicated in various pathological conditions such as Cushing's disease, where excess ACTH leads to elevated cortisol levels, resulting in metabolic and cardiovascular complications. ACTH acts on the melanocortin 2 receptor (MC2R) on the adrenal cortex, triggering a cascade that leads to the synthesis and release of cortisol. This hormone is involved in numerous physiological processes, including metabolism regulation, immune response modulation, and maintenance of homeostasis. Pharmacokinetic properties of ACTH include a pulsatile secretion pattern, influenced by the circadian rhythm and stress factors. The half-life of endogenous ACTH is relatively short, necessitating its continuous production for sustained action. Clinically, ACTH is used in diagnostic testing for adrenal insufficiency and as a therapeutic agent in certain inflammatory and autoimmune conditions. It is regulated as a prescription medication in many countries, reflecting its significant physiological impact and potential for misuse.
| Formel | C207H308N56O58S |
| Molekulargewicht | 4541g/mol |
| CAS-Nummer | 9002-60-2 |
| PubChem CID | 16132265 |
ACTH acts primarily on the melanocortin 2 receptor (MC2R) located on the adrenal cortex, initiating a signaling cascade that results in the production and release of cortisol. This process involves the activation of adenylate cyclase, increasing cyclic AMP (cAMP) levels and stimulating steroidogenesis.
Adrenocorticotropic hormone (ACTH) primarily exerts its effects through the activation of melanocortin 2 receptors (MC2R) on adrenal cortical cells, initiating the cAMP/PKA signaling pathway. This activation stimulates the synthesis and secretion of glucocorticoids, particularly cortisol, from the adrenal cortex, thereby influencing various biological processes such as metabolism, immune response, and stress adaptation. The precise regulatory mechanisms of ACTH action, particularly in pathological states like Cushing's disease, remain an area of ongoing research.
Pulsatile, varies by time of day
Circulating half-life ~10 minutes
Endogenous ACTH has a short half-life, necessitating continuous secretion for sustained physiological effects.
Temperature
Refrigerate at 2-8C
Light
Protect from light
Form
Aqueous solution: use within specified period after opening
Notes
Ensure proper storage conditions to maintain stability and efficacy.
ACTH is soluble in water, facilitating its formulation as an aqueous solution for clinical use.
🇩🇪DE
Verschreibungspflichtig (prescription only), not listed under BtMG.
🇺🇸US
FDA approved for diagnostic and therapeutic use; prescription required.
🇦🇺AU
TGA Schedule 4 (prescription only medicine).
🇬🇧UK
Prescription only medicine (POM) under MHRA regulations.
Legal status information is provided for general reference only and may not reflect the most current regulatory changes. Always verify with official government sources before making any decisions.
Current evidence is limited regarding the long-term outcomes and quality of life in patients with Cushing's syndrome post-treatment, particularly in relation to the management of residual ACTH levels and their impact on morbidity and mortality. Further research is needed to explore the efficacy of CRF1 receptor antagonists like crinecerfont in diverse populations, including pediatric patients and those with varying degrees of disease severity. Additionally, larger randomized controlled trials are required to clarify the biological significance of different forms of ACTH, such as big ACTH, and their roles in various pathologies, including lung carcinoma and other malignancies.
2,626
Total Citations
16
Human/RCT
3.6
Avg. Influence
2025
Latest
Researchers observed that major depression is associated with altered HPA axis physiology, including hypersecretion of ACTH and cortisol during acute episodes.
The study demonstrated that the hypothalamic-pituitary-adrenal axis, regulated by CRH and AVP, is crucial for cortisol synthesis and release in response to stress.
Researchers observed that immunoneutralization of corticotropin-releasing factor significantly reduced ACTH secretion in rats, indicating its physiological role in regulating ACTH release.
Lonser Russell R, et al. · Journal of neurosurgery · 2017
Researchers observed that successful resection of ACTH-secreting pituitary adenomas in Cushing's disease leads to immediate biochemical remission and preservation of pituitary function.
Key findings
The review highlighted that adrenocorticotropic hormone has antiproteinuric and renoprotective properties in nephrotic syndrome, suggesting its potential effectiveness in patients resistant to steroids and other immunosuppressants.
The study demonstrated that interleukin-1 beta infusion significantly increased the release of corticotropin-releasing hormone and ACTH in free-moving rats, indicating an interaction between the neuroendocrine and immune systems.
Researchers observed that maternal plasma corticotropin-releasing hormone levels correlate with ACTH and cortisol during pregnancy, indicating its role as a stimulator of the maternal pituitary-adrenal axis.
The review detailed that corticotropin-releasing factor in the hypothalamus regulates the stress response by stimulating adrenocorticotropic hormone release, with various factors contributing to stress resilience.
The study demonstrated that urocortin is more potent than corticotropin-releasing hormone in stimulating ACTH secretion in rat anterior pituitary cells both in vivo and in vitro.
Researchers observed that ACTH is produced in the pituitary gland of common carp and is regulated by factors from the nucleus preopticus, with dopamine exerting predominant inhibitory control over its release.
32
Total Trials
1,086
Total Enrolled
University of Wuerzburg
62
2005
serum cortisol-peak 30 min after ACTH-stimulation
University of Patras
60
2018
Pain VAS
Greater Boston Medical Associates
40
2017
level of proteinuria
The Cleveland Clinic
22
2011
Pearson Correlation of the Total Cortisol Levels Between the ITT and CSTs
Ronald J. Rapoport, MD
10
2014
Percentage of patients with reduction of >1.2 points in DAS-28 score
The Cleveland Clinic
9
2016
Percentage of Patients With Clinically Significant Improvement in Visual Acuity
Southeast Renal Research Institute
2012
Reduction of proteinuria in idiopathic membranous glomerulonephritis (MGN) and other forms of glomerulopathy including focal segmental glomerulosclerosis (FSGS) and advanced diabetic nephropathy
Mallinckrodt
259
2016
Part 1: Number of Participants With Low Disease Activity (LDA) by Visit
Mallinckrodt
60
2011
Percentage of Participants With Complete or Partial Remission in Proteinuria at 24 Weeks
University of Colorado, Denver
37
2013
Retinal Nerve Fiber Layer (RNFL) thickness
Mallinckrodt ARD LLC
35
2017
Score on the Expanded Disability Status Scale (EDSS) at Baseline and Day 42
Iraj Sabahi Research Inc.
30
2017
ACR 20 response ACR 20 response
Toyos Clinic
20
2025
Visual Analog scale for injection comfort
Weill Medical College of Cornell University
15
2016
Change in Myelin Water Fraction (MWF) Within New Enhancing Lesions Over the Course of 12 Months
University of California, San Francisco
14
2022
Decrease in blood CXCL9 levels by 50%
Columbia University
8
2014
Number of Patients With a Complete Response (CR)
Wayne State University
8
2013
Neuroinflammation in cortical and/or subcortical structures
Tampa Bay Uveitis Center, LLC
6
2016
Number of Participants With Photographic Haze Reduced to Grade 0 or Down 2 Steps Documented With Fundus Photography
University of Chicago
5
2016
Change in T1 Lesion Relaxation Time
Mallinckrodt
5
2018
Score on the Nussenblatt Grading Scale
Washington University School of Medicine
2
2016
Change From Baseline in Eye With Uveitis of Anterior Chamber Cellularity Graded From 0-4 on a Likert Scale Determined by Slit Lamp Examination
All India Institute of Medical Sciences
40
2024
Change in Cortical Excitability
Neurologique Foundation, Inc.
30
2009
Improvement in EDSS (Expanded Disability Status Scale) and Kurtzke Functional Scale (to assess individual disabilities).
Albany Medical College
10
2015
Reduction of 24 hour urine calcium
University of Minnesota
59
2014
Proportion of Patients Exhibiting a 20% Worsening in T25FW at 36 Months
Dartmouth-Hitchcock Medical Center
15
2014
Improvement in Disease Activity as Measured by ACR20 and ACR50.
Rohit Aggarwal, MD
12
2013
Specific Aim 1: Number of Subjects Meeting IMACS Preliminary Definition of Improvement (DOI).
Mayo Clinic
20
2009
Change in proteinuria
Youngstown State University
9
2015
Renal Function
University of Virginia
144
2019
Change in calculated free testosterone concentrations
National Institute of Neurological Disorders and Stroke (NINDS)
30
2011
To determine effect of CRH stimulation on 18F-FDG uptake in high-resolution PET-imaging of ACTH-adenomas in CD.
Nationwide Children's Hospital
10
2017
Difference between VEGF levels at baseline and the peak VEGF level after low dose cosyntropin administration in healthy children and adolescents
Log cycles, set reminders and visualize serum levels.
This page is for informational and research purposes only. All information is based on published scientific literature and does not constitute medical advice, diagnosis, or treatment recommendations. Many substances listed may not be approved for human use and may be subject to drug regulation laws (e.g., AMG in Germany, FDA in the US). PepStack does not encourage the use of any substance on humans. Always consult a qualified healthcare professional before making any health-related decisions. Use of this information is entirely at your own risk. PepStack assumes no liability for the accuracy, completeness, or timeliness of the content provided. Full disclaimer